Conference on Normal Tissue Radiation Effects and Countermeasures (CONTREC), a Winthrop Rockefeller Conference

May 6, 2015 · 6:00 PM – May 9, 2015 · 12:00 PM


About the conference

The Conference on Normal Tissue Radiation Effects and Countermeasures (CONTREC) was first held at the Winthrop Rockefeller Institute May 6-9, 2015, bringing together more than 75 national and international researchers that were able to share their work, while also showcasing the groundbreaking work at the University of Arkansas for Medical Sciences’ Division of Radiation health.

CONTREC was held in partnership with the University of Arkansas for Medical Sciences’ Division of Radiation Health and the Winthrop Rockefeller Institute. The conference was made possible by generous support from the Winthrop Rockefeller Charitable Trust with additional major sponsorships from the UAMS College of Pharmacy, the UAMS Winthrop P. Rockefeller Cancer Institute and the Arkansas Biosciences Institute.

Reviews from the 2015 conference:

“Thank you so much for the invitation to join the CONTREC meeting this week – what an amazing job you did at putting together this meeting. It was a real privilege to meet so many international experts in the field, and I learned a great deal about the radiation field from both presentations and discussions. Thanks to you, I have invitations from NIAID, NCI, AFFRI, and the National Space BRI to visit and/or develop research proposals, all of which may be able to provide funding. In addition, there were great discussions with Jervoise, Mohan and Chandan about working together on scientific/clinical projects. Lots of great stuff to think about over the next few weeks. Thanks again for the opportunity to be part of this.”

“Just a quick word of appreciation for the opportunity to visit Arkansas. The CONTREC meeting was excellent and I enjoyed seeing old friends and making new ones. As you have mentioned already, the staff at the Winthrop Rockefeller Institute did a fabulous job in hosting the event.”

“I would like to thank you for all the work done by you and your team in the organization of the CONTREC meeting. It was a great event, with very high level of presentations from different perspectives concerning radiation effects in where we learn, share and interact in a very dynamic and friendly way. In addition, the social events were also a nice opportunity to consolidate a group in the scientific community with an excellent organization. As well as the lunches and dinners.”

Featured Speakers Included:

Jervoise Andreyev, M.D., Ph.D.

Royal Marsden Hospital, United Kingdom

Dr. Jervoise Andreyev is a consultant gastroenterologist in GI Consequences of Cancer Therapy at The Royal Marsden Hospital in London, U.K., Europe’s largest comprehensive cancer center. He is likely the only consultant gastroenterologist in the world appointed specifically to treat the side effects of cancer treatments. He is widely regarded as a pioneer in advancing the clinical treatment of bowel complications of radiotherapy. Together with international collaborators, he has defined a new disease entity, “Pelvic Radiation Disease,” a term that has been widely adopted in the U.K. and is increasingly being used elsewhere.

Jim Denham, M.D.

Newcastle University, Australia

Dr. Jim Denham has a distinguished track record in clinical cancer research, having successfully coordinated many trials in the pursuit of improved treatments for people with cancers such as esophageal, head and neck, breast and prostate. Denham’s current research in prostate cancer illustrates the real contribution he is making to cancer treatment worldwide. He is coordinating one of the world’s largest prostate cancer trials, which has shown that a hormone therapy given to men with localized but inoperable prostate cancer a few months before radiotherapy can help stop their cancer returning after treatment and reduce cancer deaths.

Gregory Nelson, Ph.D.

Loma Linda University, United States

Dr. Gregory Nelson has a longstanding interest in the effects of spaceflight and space radiation on mouse brain, bone and immunity and C. elegans genomic stability and development. His work has included five spaceflight experiments and extensive research in particle accelerators simulating space radiation. He developed the research beamline for protons and supporting facilities at Loma Linda University and served as the founding director of the NASA Space Radiation Summer School. Recently, he led two NASA-sponsored projects investigating the effects of space-like radiation exposures on the mammalian nervous system.

Jacqueline Williams, Ph.D.

University of Rochester, United States

Dr. Jacqueline Williams has more than 30 years of experience in radiation biology and related fields and has participated in a broad range of research areas, including clinically related oncologic studies and clinical trials, tumor blood flow studies, and pharma­cological and toxicological projects. Her current research interests involve identifying mechanisms that underlie the initiation and progression of radiation-induced late normal tissue effects as a consequence of high-dose clinical treatment/accidental exposures or the lower doses associated with either space travel or mass exposures that may result from terrorist acts.